Moody Aldrich Partners LLC Cuts Stake in Oscar Health, Inc. (NYSE:OSCR)

Moody Aldrich Partners LLC cut its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 1.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 148,318 shares of the company’s stock after selling 2,912 shares during the period. Moody Aldrich Partners LLC owned 0.06% of Oscar Health worth $3,146,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in OSCR. Avalon Trust Co purchased a new stake in Oscar Health in the first quarter valued at about $69,000. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health during the second quarter valued at about $78,000. Quest Partners LLC purchased a new position in shares of Oscar Health in the 2nd quarter valued at approximately $93,000. Amalgamated Bank boosted its stake in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors purchased a new stake in Oscar Health during the 3rd quarter worth approximately $142,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of OSCR stock traded up $0.53 during mid-day trading on Thursday, hitting $16.47. 879,752 shares of the stock were exchanged, compared to its average volume of 3,189,871. Oscar Health, Inc. has a 52-week low of $4.72 and a 52-week high of $23.79. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.98 billion, a PE ratio of -128.84, a price-to-earnings-growth ratio of 32.39 and a beta of 1.62. The firm has a fifty day moving average of $18.87 and a 200 day moving average of $18.31.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. During the same period last year, the company earned ($0.07) earnings per share. Oscar Health’s quarterly revenue was up 44.6% compared to the same quarter last year. Research analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, EVP Ranmali Bopitiya sold 36,175 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $650,788.25. Following the completion of the sale, the executive vice president now owns 251,885 shares of the company’s stock, valued at $4,531,411.15. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock valued at $3,007,069 over the last ninety days. Corporate insiders own 25.11% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on OSCR shares. UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Piper Sandler reaffirmed an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Three investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $24.00.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.